Express News | NYSE Order Imbalance 108715.0 Shares on Buy Side
Envista Announces Participation in Stifel Jaws & Paws Conference
Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Stifel Jaws & Paws Conference on...
Express News | NYSE Order Imbalance 68452.0 Shares on Buy Side
Express News | Envista Holdings Corp : Jefferies Cuts to Hold From Buy
Express News | Envista Holdings Corp : Deutsche Bank Cuts Target Price to $7 From $9
Envista Holdings Corporation (NYSE:NVST) Shares Could Be 40% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Envista Holdings fair value estimate is US$31.96 Envista Holdings is estimated to be 40% undervalued based on current share price of US$19.28
Express News | NYSE Order Imbalance 116462.0 Shares on Buy Side
Express News | NYSE Order Imbalance 57260.0 Shares on Buy Side
Envista Holdings Corporation Just Missed Earnings - But Analysts Have Updated Their Models
Envista Holdings Is Maintained at Sell by Goldman Sachs
Envista Holdings Is Maintained at Sell by Goldman Sachs
Express News | Goldman Sachs Maintains Sell on Envista Holdings, Lowers Price Target to $17.5
Is Envista Holdings Corporation (NYSE:NVST) Trading At A 36% Discount?
Envista Holdings' Leadership Shuffle: Navigating Risks and Stakeholder Confidence Amidst Executive Changes
Express News | NYSE Order Imbalance 131817.0 Shares on Sell Side
Envista Holdings Price Target Cut to $23.00/Share From $29.00 by JP Morgan
Envista Holdings Price Target Cut to $23.00/Share From $29.00 by JP Morgan
Unveiling 4 Analyst Insights On Envista Holdings
During the last three months, 4 analysts shared their evaluations of Envista Holdings (NYSE:NVST), revealing diverse outlooks from bullish to bearish.The following table provides a quick overview of t
Earnings Call Summary | Envista Holdings(NVST.US) Q1 2024 Earnings Conference
The following is a summary of the Envista Holdings Corporation (NVST) Q1 2024 Earnings Call Transcript:Financial Performance:Envista reported Q1 sales of $623.6 million with a core sales growth of 0.4
Envista Holdings Is Maintained at Neutral by Baird
Envista Holdings Is Maintained at Neutral by Baird
Baird Maintains Neutral on Envista Holdings, Lowers Price Target to $19
Baird analyst Jeff Johnson maintains Envista Holdings (NYSE:NVST) with a Neutral and lowers the price target from $22 to $19.
Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO) and Envista Holdings (NVST)